Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT07222475 · ClinicalTrials.gov registry record · NA

Writing Relaxing Beats in Adolescents Who Have Sickle Cell Disease

A NA study of Sickle Cell Disease, sponsored by Mayo Clinic.

Recruiting
Registry status
NA
Development phase
30
Enrollment target
1
Study location

NCT07222475 is a NA study of Sickle Cell Disease that is actively recruiting participants, run by Mayo Clinic. The registered enrollment target is 30 participants, below the 293-participant average among 213 other Sickle Cell Disease trials with a reported enrollment target (90% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT07222475, a NA study of Sickle Cell Disease, is actively recruiting participants, sponsored by Mayo Clinic.

RECRUITING
Registry status
NA
Development phase
30 participants
Enrollment target
1
Study location

Study Summary

This research aims to see if songwriting can help reduce anxiety in adolescents with Sickle Cell Disease. The purpose of the study is to discover if participants find songwriting and playing their songs to be practical and acceptable, and helpful for managing anxiety.

Conditions Studied

Interventions

  • BEHAVIORAL Songwriting intervention (active music therapy)

Study Locations (1)

Minnesota

  • Mayo Clinic Division of Nursing - Rochester

Trial Details

FieldValue
Enrollment Target 30 participants
Start Date 2026-02-05
Est. Completion 2026-07-31
Phase NA

Sponsor

Mayo Clinic

2,844 total trials

What the Registry Record Tells You About NCT07222475

The ClinicalTrials.gov registry entry for NCT07222475 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 30 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 293-participant average among 213 other Sickle Cell Disease trials with a reported enrollment target (90% lower). The listed sponsor is Mayo Clinic, which has 2,844 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Sickle Cell Disease appearing as the primary indexed condition, and to 1 intervention - of which Songwriting intervention (active music therapy) is the first listed.

NCT07222475 reports 1 study location spanning 1 distinct geographic area - top geographies include Minnesota.

Frequently Asked Questions

What is clinical trial NCT07222475 about?

NCT07222475 is a clinical study titled "Writing Relaxing Beats in Adolescents Who Have Sickle Cell Disease". This research aims to see if songwriting can help reduce anxiety in adolescents with Sickle Cell Disease. The purpose of the study is to discover if participants find songwriting and playing their songs to be practical and acceptable, and helpful for managing anxiety.

What is the current status of trial NCT07222475?

This trial is currently recruiting. It is a NA study. The enrollment target is 30 participants. The study started on 2026-02-05. Estimated completion is 2026-07-31.

What conditions does trial NCT07222475 study?

This clinical trial studies the following conditions: Sickle Cell Disease.

What interventions are being tested in trial NCT07222475?

The interventions under investigation include: Songwriting intervention (active music therapy) (BEHAVIORAL).

Who is sponsoring clinical trial NCT07222475?

This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT07222475 being conducted?

This trial has 1 study location across Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Sickle Cell Disease

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.